Behavioral health startup NeuroFlow secures series B investment backed by Magellan Health
Summary
NeuroFlow’s platform aggregates mental health data and builds comprehensive patient profiles, which care teams can use to identify patterns and treatment decisions. The companys contracted user base has grown 10x times to over 330,000 and it works with more than 200 commercial health systems, payers, accountable care organizations, independent medical groups and federal agencies. NeuroFlow will use the fresh capital to scale its operations and support its growth in data analytics, artificial intelligence, and direct health record integrations, the company said. Most healthcare providers are overburdened, so introducing the concept to account for a person’s mental health in addition to their primary specialty can be overwhelming and lead to inconsistent and inadequate treatment,” said NeuroFlow CEO Chris Molaro in a statement. This partnership is beneficial in achieving the best outcomes through measurement-based care, and best in class technology," said Ken Fasola, chief executive officer, Magellan Health.
Funding
Classifications
AskAI Classifications
LabelsLinked Companies
